Related Experiment Video
Updated: Apr 13, 2026

Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice
Published on: May 2, 2025
Uncovering potential biomarkers for chronic kidney disease of unknown etiology through a network-based bioinformatic
Aleeta Maria Jolly1, Sonu Benny2, Aneesh Thankappan Presanna2
1Department of Pharmacology, Amrita Vishwa Vidyapeetham-Kochi Campus, Amrita School of Pharmacy, Kochi, Kerala, India.
Insights
Chronic kidney disease of unknown cause (CKDu) involves tubular injury. This study identified key genes like SPP1, TNF, and IL-6, crucial for CKDu initiation and progression, suggesting potential biomarkers.
Area of Science:
- Nephrology
- Bioinformatics
- Molecular Biology
Background:
- Chronic kidney disease of unknown cause (CKDu) is defined by a sustained decline in estimated glomerular filtration rate (eGFR) without identifiable risk factors.
- Biopsy studies indicate that renal tubular injury plays a significant role in the pathogenesis of CKDu.
Purpose of the Study:
- To employ a network-based bioinformatics approach to identify potential biomarkers and elucidate their roles in CKDu.
- To pinpoint key genes and pathways implicated in the initiation and progression of renal tubular injury in CKDu.
Main Methods:
- Conducted a comprehensive literature survey across PubMed, Scopus, and Science Direct, focusing on renal tubular injury markers.
- Utilized network analysis with Cytoscape and enrichment analysis with Cluego on 43 identified genes associated with CKDu.
- Analyzed topological properties and functional enrichment of selected genes to identify hub genes and biological pathways.
Main Results:
- Identified 37 biomarkers and 43 corresponding genes from 40 research articles related to CKDu.
- SPP1 emerged as the hub gene, with SPP1, TNF, CLU, CST3, CRP, TGFB1, and IL-6 ranking highest in network centrality.
- Functional analysis indicated localization to collagen type IV trimers in renal tubules and monooxygenase activity for detoxification, with TLR signaling implicated in inflammation.
Conclusions:
- The identified genes (SPP1, TNF, CLU, CST3, CRP, TGFB1, IL-6) are critically involved in the initiation and progression of CKDu.
- These genes and associated pathways represent promising candidates for further investigation as diagnostic and prognostic biomarkers for CKDu.
- Biological validation studies are necessary to confirm the biomarker potential of these identified genes in CKDu.
Abstract:
CKDu is a renal disorder characterized by a decline in eGFR < 60 mL/min/1.73 m2 for a period of ≥ 3 months without any known risk factors. Biopsy reports in various case studies revealed the role of tubular injury in CKDu. We adopted a network-based bioinformatic approach to identify biomarkers and their role in CKDu. Through literature survey, 216 articles from Science Direct, PubMed, and Scopus were identified; 57 articles were selected on renal tubular injury markers, whereas 159 articles were not either research or on renal tubular injury markers. After excluding 17 duplicate articles, we found 40 research articles on various biomarkers of CKDu. Out of 40 research articles, we identified 37 biomarkers and 43 corresponding genes. Network centrality of these 43 genes with CKDu was performed using Cytoscape and enrichment analysis using Cluego. Out of selected 43 genes, topological enrichment interpretations revealed SPP1 as the hub gene, with top rank and scores. SPP1, TNF, CLU, CST3, CRP, TGFB1, and IL-6 genes had the top 5 rank and scores. Functional enrichment analysis revealed that cellular components were localized to collagen type IV trimer in the renal tubules; molecular enrichment analysis showed monooxygenase activity in kidney for detoxification. Reactome pathway accounts for TLR by endogenous ligand in renal cells upon inflammation as a possible mechanism behind CKDu. SPP1, TNF, CLU, CST3, CRP, TGFB1, and IL-6 genes were identified to play an important role in the initiation and progression of CKDu. Further biological validation studies are required to check their potential to act as biomarkers.
Related Concept Videos
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease III: Interprofessional Care
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration
Drug Dosing in Renal Diseases: Measurement of Glomerular Filtration Rate
Acute Kidney Injury IV: Diagnostic Studies and Prevention
